Objectives YM155, an inhibitor of interleukin enhancer-binding factor 3 (ILF3), significantly
suppresses cancer stemness property, implying that ILF3 contributes to cell survival of …

Transcription factor Krüppel-like factors 5 (KLF5) is overexpressed in a wide range of tumor
tissues and acts as a prognostic factor in cancer. However, the role of KLF5 in non-small cell …

Interleukin enhancer‑binding factor 3 (ILF3) may function as a transcriptional coactivator and
has been reported to be involved in tumor proliferation and metastasis; however, its role and …

Background Proteasome 26S subunit, non-ATPase 3 (PSMD3) has been reported to
participate in various human cancers. Nevertheless, the function of PSMD3 in lung cancer …

Emerging data indicate that interferon‐induced transmembrane protein 1 (IFITM1) plays an
important role in many cancers. However, it remains unclear whether IFITM1 is functionally …

This study aimed to investigate the expression and function of interferon regulatory factor-1
(IRF-1) in non-small cell lung cancer (NSCLC). IRF-1 expression and its prognostic value …

Immunotherapy can improve the survival of patients with advanced lung squamous cell
carcinoma (LUSC). T cytotoxic cells are one of the main members of the immune …

Previous studies have demonstrated that the interleukin (IL)‑6/IL‑6 receptor (IL‑6R) signaling
pathway contributes to the pathogenesis of lung cancer. Lung adenocarcinoma (LUAD) and …

Numerous evidence showed that the occurrence and development of lung cancer is closely
related to environmental pollution. Therefore, new environmental response predictive …

Objective. This study was designed to explore the role and mechanism of eukaryotic
initiation factor 3C (EIF3C) in the proliferation and apoptosis of lung cancer cells. Methods …